Pinto Beans & Penny Stocks 2020

[brudiver]

KKUR (.0018) News~

RENO, NV -- (MARKET WIRE) -- 07/09/09 -- ChromoCure, Inc. (PINKSHEETS: KKUR) announced today it received its ticker symbol and initiates its business plan accordingly. The company has completed the corporate action review process with FINRA. No reverse-split of the company's stock occurred as part of the company's recent restructuring and corporate action. All stockholders retain the same number of shares they owned prior to the company's re-structuring. The following press release outlines various items to be executed by the Company in the coming days and weeks.

The company intends to execute and timely update investors on the following:

-- Total elimination of prior corporate debt and addition of new
technology assets.

-- Full activation of the Company on the OTC Disclosure Service to
provide transparency and regular public information. This will also remove
the unwanted "Caveat Emptor" flag associated with the company's prior
operations.

-- Investors will be updated on new appointments of MD's and other
industry professionals to the Company's Advisory and Business Development
Boards.

-- Guidance on 2009 revenues and sales projections.

-- New additions to the Company's pathology and cancer labs revenue
partners

-- New installations of the Company's Chromosomal Scanner

-- New technology and vendor agreements for national joint venture
marketing and sales

-- Full business plan information and regular technology briefings on the
company's cancer detection technologies


About Us

ChromoCure develops and provides cancer detection systems to diagnostic labs. The systems are provided by the Company and installed on a revenue sharing basis. The Company's systems measure the unique genomic characteristic common to all cancers. This characteristic is never found in normal cells. The Company believes its detection technology has an effective accuracy of 100% for all cancers at all stages. The Company also applies its science and technology to non-toxic and non-invasive approaches to cancer therapy and cure research. Web: http://www.chromocure.com